A recently-developed and highly sensitive antibody test can detect whether a person has had COVID-19 or not.
The new antibody test has been developed from scratch in close collaboration between Rigshospitalet, the University of Copenhagen and Novo Nordisk A/S, with support from the Carlsberg Foundation and the Novo Nordisk Foundation. The test can make a major contribution to monitoring the transmission of COVID-19 during the pandemic and the antibody development at the individual level and in society as a whole.
In the film above, Peter Garred, Professor, Centre of Diagnostic Investigation, Rigshospitalet and Mads Krogsgaard Thomsen, Executive Vice President, Novo Nordisk A/S explain how the test works and discuss the significance of the public–private partnership that has enabled the test to be developed in recent months.
The final trials of the test have just ended, and the results are so convincing that it is possible to start testing up to 5,000 people a day. However, a decision on how the new test will be utilized has yet to be taken.
The Foundation awarded Peter Garred a grant of DKK 4.8 million for the antibody test project The Copenhagen SARS-CoV-2 Antibody Testing Initiative.
Read more about the new test on the Rigshospitalet website. (currently in Danish)
In the film, Peter Garred, Professor, Centre of Diagnostic Investigation, Rigshospitalet and Mads Krogsgaard Thomsen, Executive Vice President, Novo Nordisk A/S explain how the new Danish antibody test, which can reveal who has had COVID-19, works.
Further information
Christian Mostrup, Senior Programme Lead,
+45 3067 4805, [email protected]
